 |
|
rofecoxib
A synthetic, nonsteroidal derivative of phenyl-furanone with antiinflammatory, antipyretic and analgesic properties and potential antineoplastic properties. Rofecoxib binds to and inhibits the enzyme cyclooxygenase-2 (COX-2), resulting in an inhibition of the conversion of arachidonic acid to prostaglandins. COX-related metabolic pathways may represent key regulators of cell proliferation and neo-angiogenesis. Some epithelial tumor cell types overexpress pro-angiogenic COX-2. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| US brand name: | | Vioxx | | | | Code name: | | MK 966 | | | | Chemical structure name: | | 4-[4'-(Methylsulfonyl)phenyl]-3-phenyl-2(5H)-furanone | | |
|
|
